ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

ClinicalTrials.gov ID: NCT03541200

Public ClinicalTrials.gov record NCT03541200. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 8:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Long Term Extension Study of MT-8554 in Postmenopausal Women Experiencing Moderate to Severe Vasomotor Symptoms Who Completed Study MT-8554-A01

Study identification

NCT ID
NCT03541200
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Tanabe Pharma America, Inc.
Industry
Enrollment
190 participants

Conditions and interventions

Interventions

  • MT-8554 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 17, 2018
Primary completion
Nov 14, 2019
Completion
Nov 14, 2019
Last update posted
Jan 22, 2026

2018 – 2019

United States locations

U.S. sites
53
U.S. states
24
U.S. cities
49
Facility City State ZIP Site status
Research Site Birmingham Alabama 35209
Research Site Dothan Alabama 36303
Research Site Phoenix Arizona 85032
Research Site Norwalk California 90650
Research Site Sacramento California 94203
Research Site San Diego California 92111
Research Site Denver Colorado 80209
Research Site New London Connecticut 33176
Research Site Clearwater Florida 33759
Research Site Crystal River Florida 34429
Research Site Fort Myers Florida 33900
Research Site Hialeah Florida 33012
Research Site Hialeah Florida 33016
Research Site Jacksonville Florida 32256
Research Site Jupiter Florida 33458
Research Site Miami Florida 33176
Research Site Miami Florida 33185
Research Site Orlando Florida 32801
Research Site Orlando Florida 32806
Research Site Ponte Vedra Florida 32081
Research Site Port Saint Lucie Florida 34952
Research Site Sarasota Florida 34231
Research Site Wellington Florida 33414
Research Site West Palm Beach Florida 33409
Research Site Sandy Springs Georgia 30328
Research Site Idaho Falls Idaho 83404
Research Site Hutchinson Kansas 67501
Research Site Wichita Kansas 67226
Research Site Marrero Louisiana 70072
Research Site Metairie Louisiana 70001
Research Site Baltimore Maryland 21208
Research Site Kalamazoo Michigan 49009
Research Site Saginaw Michigan 48504
Research Site Kansas City Missouri 64114
Research Site Missoula Montana 59801
Research Site Las Vegas Nevada 89128
Research Site Lawrenceville New Jersey 08648
Research Site Morehead City North Carolina 28557
Research Site Winston-Salem North Carolina 27103
Research Site Cleveland Ohio 44101
Research Site Columbus Ohio 43213
Research Site Columbus Ohio 43231
Research Site Englewood Ohio 45322
Research Site Philadelphia Pennsylvania 19114
Research Site Bristol Tennessee 37620
Research Site Jackson Tennessee 38305
Research Site Memphis Tennessee 38119
Research Site Fort Worth Texas 76104
Research Site Schertz Texas 78154
Research Site Draper Utah 84020
Research Site Salt Lake City Utah 84107
Research Site Norfolk Virginia 23502
Research Site Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03541200, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 22, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03541200 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →